ICA USA published their list of 34 fellowships available for funding in 2017. Institutes include Assuta Medical Center, Bar-Ilan University, Ben-Gurion University of the Negev, Hadassah Medical Center, The Hebrew University of Jerusalem, Rabin Medical Center, Rambam Healthcare Campus, Sheba Medical Center, Technion, Israel Institute of Technology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv-Yaffo Academic College, Schneider Children’s Medical Center, University of Haifa, MIGAL-Galilee Research Institute and Weizmann Institute of Science.
For more information or individual fellowship abstracts please call ICA USA at 561-832-9277. To have us contact you about funding a 2016 Fellowship, complete the Fellowship Inquiry Contact Form here.
Descriptions of 2017 Fellowships:
Technion, Israel Institute of Technology, Prof. Nabieh Ayoub
Characterizing the novel role of the tumor suppressor gene, RBM6 in DNA damage response.
Ben-Gurion University of the Negev, Dr. Moshe Elkabets
Activation of MET/HGF pathways confers resistance to cetuxumab in Head and Neck Cancer.
Tel-Aviv University, Prof. Gil Ast
Analysis of regulatory pathways leading to alternative splicing aberrations in ovarian and colon cancers.
Rambam Healthcare Campus, Dr. Shlomit Strulov Shachar
Geratric assessment & muscle indices as predictive factors for treatment-related toxicity and time to tumor progression (TTP) in elderly patients with advanced Lung and Breast Cancer.
Rambam Healthcare Campus, Dr. Ital Maza
Methylation Dynamics in Adenoma to Carcinoma Sequence of Sporadic Colorectal Cancer.
Tel Aviv University, Prof. Ron Shamir
Integrative computational analysis of molecular data from cancer patients. Bioinformatics (computational biology) is a new field that uses techniques from computer science and mathematics to solve problems in biology and medicine, by developing advanced computational techniques. Due to the enormous volume of data in cancer research, analysis cannot be done efficiently without bioinformatics.
Tel Aviv University, Prof. Haim Werner
Identification of thioredoxin-interacting protein (TXNIP as a novel metabloc tumor suppressor gene (Thyroid Cancers).
Rambam Helathcare Campus, Dr. Na’ara Shorook
Mechanisms of Radioiodine Resistance in Papillary Thyroid Carcinoma.
Ben-Gurion University of the Negev, Prof. Ruti Parvari
Study of the molecular basis of non-Medullary Thyroid Cancer by identification and characterization of the mutated gene causing it in a large family and its contribution in isolated cases.
Sheba Medical Center , Dr. Yaacov Lawrence
Celiac Plexus Radio-Surgery for Pain Management in Advanced Cancer Patients – a Phase II Trial
Technion, Israel Institute of Technology, Prof. Doron Melamed
Targeting biogenesis of microRNAs for effective immunotherapy of B-cell cancer.
Schneider Children’s Medical Center, Dr. Sara Elitzur
Assessment of fertility and ovarian reserve in female survivors of Acute Lymphoblastic Leukemia (ALL).
Rabin Medical Center Beilinson Campus, Prof. Ronit Abir
Culture of human primordial follicles with neuronal growth factors for fertility restoration after anti-cancer therapy.
Rambam Healthcare Campus, Dr. Shlomit Yehudai-Reshef
The role of bone marrow stromal cells in Acute Myeloid Leukemia initiation and relapse progression
Bar-Ilan University, Prof. Shulamit Michaeli
Development of innovative iron oxide nanoparticles for targeting and silencing of Ovarian Cancer.
The Hebrew University of Jerusalem, Dr. Maayan Salton
Chromatin regulation of alternative splicing by p300 in Breast Cancer.